top of page

Revolutionizing the
Clinical Management
of Aneurysm Patients

Technology

Abdominal Aortic Aneurysms

An abdominal aortic aneurysm (AAA) is a ballooning of the aorta that will continue to grow if left untreated and can rupture. There are 200,000 diagnoses annually in the United States. Clinicians still use the outdated one-size-fits-all maximum diameter criterion to decide when to intervene. If the patients are below the threshold (5.0 cm for women and 5.5 cm for men), they will be monitored until they are offered surgical intervention. However, it has been reported that between 7-23.4% of aneurysms can rupture before this threshold, making AAA rupture the 13th leading cause of death in the United States.

MicrosoftTeams-image_edited.jpg

13th
leading cause of death

image2.png

2 million
AAA in the U.S.

image.png

7-23.4%
rupture before threshold

image3.png

AI-Backed Clinical Decision Making

Aneurisk Inc. allows artificial intelligence to be coupled with CT scans and other patient data to improve the prognosis and management of abdominal aortic aneurysms. Our team has developed an automated pipeline that utilizes medical images and patient clinical data to provide a comprehensive view of a patient's aneurysm to improve outcomes. Our clinical decision support tool could reduce surveillance intervals for imaging, reduce rupture events, identify high-risk aneurysms, and reduce unnecessary surgery.

Aneurisk Team


Timothy K. Chung, PhD

Chief Technology Officer

Assistant Professor of Bioengineering

 

Tim Chung
  • LinkedIn
Micah.jpeg


Micah Guffey

Director of Operations

 

  • LinkedIn
Dr. Nathan Liang


Nathan L. Liang, MD, MS

Chief Executive/Medical Officer 
Assistant Professor of Surgery

  • LinkedIn
IMG_3761_edited.jpg


Christopher Niles

Lead Software Developer

 

  • LinkedIn
Dr. David Vorp


David A. Vorp, PhD

Chief Scientific Officer 
Professor of Bioengineering

  • LinkedIn
thumbnail_IMG_0008_edited.jpg


Brian Jeon, PhD

Director of R&D

  • LinkedIn
Team
bottom of page